Glomerular Ultrastructural Changes in Microalbuminuric IDDM-Patients

  • Hans-Jacob Bangstad
  • Ruth Østerby


Since the term »microalbuminuria« (MA) was coined in 1982 [1] elevated albumin excretion rate has been regarded as the best indicator to signal early diabetic nephropathy [2–5]. Two main aspects of renal function at this stage of diabetic nephropathy, are the relation to glomerular structure and the impact of blood glucose control. Improved blood glucose control has been shown to reduce the risk of developing overt nephropathy in patients with MA [6,7] and retard the progression of AER [8], but the concomitant ultrastructural changes were not investigated.


Diabetic Nephropathy Glomerular Basement Membrane Blood Glucose Control Continuous Subcutaneous Insulin Infusion Pancreas Transplantation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Viberti GC, Mackintosh D, Bilous RW, Pickup JC, Keen H. Proteinuria in diabetes mellitus: Role of spontaneous and experimental variation of glycemia. Kidney Int 1982; 21: 714–720.PubMedCrossRefGoogle Scholar
  2. 2.
    Parving H-H, Oxenbøll B, Svendsen PAA, Christiansen JS, Andersen AR. Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) 1982; 100: 500–505.Google Scholar
  3. 3.
    Viberti GC, Hill RD, Jarrett RI, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982; i: 1430–1432.CrossRefGoogle Scholar
  4. 4.
    Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984; 311: 89–93.PubMedCrossRefGoogle Scholar
  5. 5.
    Mathiesen ER, Oxenbøll B, Johansen K, Svendsen PA, Deckert T. Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 1984; 26: 406–410.PubMedCrossRefGoogle Scholar
  6. 6.
    Feldt-Rasmussen B, Mathiesen ER, Jensen T, Lauritzen T, Deckert T. Effect of improved metabolic control on loss of kidney function in type I (insulin-dependent) diabetic patients: an update of the Steno studies. Diabetologia 1991; 34: 164–170.PubMedCrossRefGoogle Scholar
  7. 7.
    Reichard P, Berglund B, Britz A, Cars I, Nilsson BY, Rosenquist U. Intensified conventional insulin treatment retards the microvascular complications of insulin dependent diabetes mellitus (IDDM): The Stockholm diabetes intervention study (SDIS) after five years. J Intern Med 1991; 230: 101–108.PubMedCrossRefGoogle Scholar
  8. 8.
    Dahl-Jørgensen K, Bjøro T, Kierulf P, Sandvik L, Bangstad H-J, Hanssen KF. Long-term glycemic control and kidney function in insulin-dependent diabetes mellitus. Kidney Int 1992; 41: 920–923.PubMedCrossRefGoogle Scholar
  9. 9.
    Østerby R. Morphometric studies of the peripheral glomerular basement membrane in early juvenile diabetes. I. Development of initial basement membrane thickening. Diabetologia 1972; 8: 84–92.PubMedCrossRefGoogle Scholar
  10. 10.
    Østerby R. A quantitative electron microscopic study of mesangial regions in glomeruli from patients with short term juvenile diabetes mellitus. Lab Invest 1973; 29: 99–110.PubMedGoogle Scholar
  11. 11.
    Gundersen HJG, Bendtsen TF, Korbo L, et al. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 1988; 96: 379–394.PubMedCrossRefGoogle Scholar
  12. 12.
    Walker JD, Close CF, Jones SL, et al. Glomerular structure in type I (insulin-dependent) diabetic patients with normo- and microalbuminuria. Kidney Int 1992; 41: 741–748.PubMedCrossRefGoogle Scholar
  13. 13.
    Bangstad H-J, Østerby R, Dahl-Jørgensen K, et al. Early glomerulopathy is present in young Type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 1993; 36: 523–529.PubMedCrossRefGoogle Scholar
  14. 14.
    Østerby R. Early phases in the development of diabetic nephropathy. Acta Med Scand 1975; 574: suppl.: 1–80.Google Scholar
  15. 15.
    Steffes MW, Sutherland DER, Goetz FC, Rich SS, Mauer SM. Studies of kidney and muscle biopsies in identical twins discordant for type 1 diabetes mellitus. N Engl J Med 1985; 312: 1281–1287.CrossRefGoogle Scholar
  16. 16.
    Chavers BM, Bilous RW, Ellis EN, Steffes MW, Mauer SM. Glomerular lesions and urinary albumin excretion in Type 1 diabetes without overt proteinuria. N Engl J Med 1989; 320: 966–970.PubMedCrossRefGoogle Scholar
  17. 17.
    Rasch R. Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment. Glomerular basement membrane thickness. Diabetologia 1979; 16: 319–324.PubMedCrossRefGoogle Scholar
  18. 18.
    Rasch R. Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment. The mesangial region. Diabetologia 1979; 17: 243–248.PubMedCrossRefGoogle Scholar
  19. 19.
    Kern TS, Engerman RL. Kidney morphology in experimental hyperglycemia. Diabetes 1987; 36: 244–249.PubMedCrossRefGoogle Scholar
  20. 20.
    Petersen J, Ross J, Rabkin R. Effect of insulin therapy on established diabetic nephropathy in rats. Diabetes 1988; 37: 1346–1350.PubMedCrossRefGoogle Scholar
  21. 21.
    Mauer SM, Brown DM, Matas AJ, Steffes MW. Effects of pancreatic islet transplantation on the increased urinary albumin excretion rates in intact and uninephrectomized rats with diabetes mellitus. Diabetes 1978; 27: 959–964.PubMedCrossRefGoogle Scholar
  22. 22.
    Steffes MW, Brown DM, Basgen JM, Mauer SM. Amelioration of mesangial volume and surface alterations following islet transplantation in diabetic rats. Diabetes 1980; 29: 509–515.PubMedGoogle Scholar
  23. 23.
    Orloff MJ, Yamanaka N, Greenleaf GE, Huang Y, Huang D, Leng X. Reversal of mesangial enlargement in rats with long-standing diabetes by whole pancreas transplantation. Diabetes 1986; 35: 347–354.PubMedCrossRefGoogle Scholar
  24. 24.
    Bilous RW, Mauer SM, Sutherland DER, Najarian JS, Goetz FC, Steffes MW. The effect of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes. N Engl J Med 1989; 321: 80–85.PubMedCrossRefGoogle Scholar
  25. 25.
    Bangstad H-J, Østerby R, Dahl-Jørgensen K, Berg KJ, Hartmann A, Hanssen KF. Improvement of blood glucose control retards the progression of morphological changes in early diabetic nephropathy. Diabetologia 1994; in press.Google Scholar
  26. 26.
    Barbosa J, Steffes MW, Connett J, Mauer M. Hyperglycemia is causally related to diabetic renal lesions. Diabetes 1992; 41: 9A.Google Scholar
  27. 27.
    Mogensen CE, Hansen KW. Blood pressure elevation versus abnormal albuminuria in the genesis and prediction of renal disease in diabetes. Diabetes Care 1992; 15: 1192–1204.PubMedCrossRefGoogle Scholar
  28. 28.
    Bangstad H-J, Kofoed-Enevoldsen A, Dahl-Jørgensen K, Hanssen KF. Glomerular charge selectivity and the influence of improved blood glucose control in Type 1 diabetic patients with microalbuminuria. Diabetologia 1992; 35: 1165–1170.PubMedCrossRefGoogle Scholar
  29. 29.
    Silbiger S, Crowley S, Shan Z, Brownlee M, Satriano J, Schlondorff D. Nonenzymatic glycation of mesangial matrix and prolonged exposure of mesangial matrix to elevated glucose reduces collagen synthesis and proteoglycan charge. Kidney Int 1993; 43: 853–864.PubMedCrossRefGoogle Scholar
  30. 30.
    Brownlee M, Spiro RG. Glomerular basement membrane metabolism in the diabetic rat: in vivo studies. Diabetes 1979; 28: 121–125.PubMedCrossRefGoogle Scholar
  31. 31.
    Cagliero E, Roth T, Roy S, Lorenzi M. Characteristics and mechanisms of high-glucose-induced overexpression of basement membrane components in cultured human endothelial cells. Diabetes 1991; 40: 102–110.PubMedCrossRefGoogle Scholar
  32. 32.
    Roy S, Sala R, Cagliero E, Lorenzi M. Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc Natl Acad Sci USA 1990; 87: 404–408.PubMedCrossRefGoogle Scholar
  33. 33.
    Ledbetter S, Copeland El, Noonan D, Vogeli G, Hassel JR. Altered steady-state mRNA levels of basement membrane proteins in diabetic mouse kidneys and thromboxane synthase inhibition. Diabetes 1990; 39: 196–203.PubMedCrossRefGoogle Scholar
  34. 34.
    Poulsom R, Kurkinen M, Prockop DJ, Boot-Handford RP. Increased steady-state levels of laminin B1 mRNA in kidneys of long term streptozotocin-diabetic rats. J Biol Chem 1988; 263: 10072–10076.PubMedGoogle Scholar
  35. 35.
    Ayo SH, Radnik RA, Garoni JA, Glass II WF, Kreisberg JI. High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am J Pathol 1990; 136: 1339–1348.PubMedGoogle Scholar
  36. 36.
    Shimomura H, Spiro RG. Studies on the macromolecular components of human glomerular basement membrane and alterations in diabetes: decreased levels of heparan sulfate proteoglycan and laminin. Diabetes 1987; 36: 374–381.PubMedCrossRefGoogle Scholar
  37. 37.
    Olgemøller B, Schwabbe S, Gerbitz KD, Schleicher ED. Elevated glucose decreases the content of a basement associated heparan sulphate proteoglycan in proliferating cultured porcine mesangial cells. Diabetologia 1992; 35: 183–186.PubMedCrossRefGoogle Scholar
  38. 38.
    Brownlee M, Vlassara H, Cerami A. Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med 1984; 101: 527–537.PubMedCrossRefGoogle Scholar
  39. 39.
    Østerby R, Nyberg G. New vessel formation in the renal corpuscles in advanced diabetic glomerulopathy. J Diabetic Complications 1987; 1: 122–127.CrossRefGoogle Scholar
  40. 40.
    Østerby R. Renal pathology in diabetes mellitus. Curr Opin Nephrol Hypertens 1993; 2: 475–483.PubMedCrossRefGoogle Scholar
  41. 41.
    Kashgarian M, Sterzel RB. The pathobiology of the mesangium. Kidney Int 1992; 41: 524–529.PubMedCrossRefGoogle Scholar
  42. 42.
    Hawkins NJ, Wakefield D, Charlesworth JA. The role of mesangial cells in glomerular pathology. Pathology 1990; 22: 24–32.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Hans-Jacob Bangstad
  • Ruth Østerby

There are no affiliations available

Personalised recommendations